Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Moran

Showing results (1-10 of 238) with videos related to

Pageof 24
Sort By:
Circulation|August 10, 2016
Still on the Road to Worldwide Hypertension ControlAndrew E Moran
Circulation|June 4, 2024
Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the UnknownAndrew E Moran, Lee Goldman
Global Heart|November 29, 2017
Secondary Prevention of CVD in LMIC: Care for the Growing Affected PopulationAndrew E Moran, Jagat Narula
American Journal of Epidemiology|June 22, 2017
Invited Commentary: Quantifying the Added Value of Repeated MeasurementsAndrew E Moran, Kiang Liu
Hypertension (Dallas, Tex. : 1979)|August 30, 2017
Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014Yiyi Zhang, Andrew E Moran
Journal of the American College of Cardiology|September 21, 2023
Implementation of Global Hearts Hypertension Control Programs in 32 Low- and Middle-Income Countries: JACC InternationalAndrew E Moran, Reena Gupta,
Global Heart|November 3, 2017
Primary Prevention in LMIC: From Population-Based Surveys to Risk Factor InterventionsAndrew E Moran, Jagat Narula
Global Heart|February 19, 2015
Scorecard for NCDsAndrew E Moran, Jagat Narula
The Medical Clinics of North America|June 5, 2017
Cardiovascular Risk AssessmentMark J Pletcher, Andrew E Moran
The New England Journal of Medicine|March 11, 2005
Isosorbide dinitrate and hydralazine in blacks with heart failureAndrew E Moran, Richard S Cooper
Pageof 24

Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Circulation|August 10, 2016
Still on the Road to Worldwide Hypertension ControlAndrew E Moran
Circulation|June 4, 2024
Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the UnknownAndrew E Moran, Lee Goldman
Global Heart|November 29, 2017
Secondary Prevention of CVD in LMIC: Care for the Growing Affected PopulationAndrew E Moran, Jagat Narula
American Journal of Epidemiology|June 22, 2017
Invited Commentary: Quantifying the Added Value of Repeated MeasurementsAndrew E Moran, Kiang Liu
Hypertension (Dallas, Tex. : 1979)|August 30, 2017
Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014Yiyi Zhang, Andrew E Moran
Journal of the American College of Cardiology|September 21, 2023
Implementation of Global Hearts Hypertension Control Programs in 32 Low- and Middle-Income Countries: JACC InternationalAndrew E Moran, Reena Gupta,
Global Heart|November 3, 2017
Primary Prevention in LMIC: From Population-Based Surveys to Risk Factor InterventionsAndrew E Moran, Jagat Narula
Global Heart|February 19, 2015
Scorecard for NCDsAndrew E Moran, Jagat Narula
The Medical Clinics of North America|June 5, 2017
Cardiovascular Risk AssessmentMark J Pletcher, Andrew E Moran
The New England Journal of Medicine|March 11, 2005
Isosorbide dinitrate and hydralazine in blacks with heart failureAndrew E Moran, Richard S Cooper
Pageof 24